# FDA Inspection 1202890 - LeMaitre Vascular Inc - March 29, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/da5dc8e4-7d6f-43ee-90bb-1d9ce355d826
Source feed: FDA_Inspections

> FDA Inspection 1202890 for LeMaitre Vascular Inc on March 29, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202890
- Company Name: LeMaitre Vascular Inc
- Inspection Date: 2023-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1202890 - 2023-03-29](https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/b2f64c33-bd29-4724-bcdd-0dc3e1a54e07)
- [FDA Inspection 1202890 - 2023-03-29](https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/ef21b5cd-2d79-442b-8557-53cd740990a6)
- [FDA Inspection 1061763 - 2018-07-11](https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/8c4cfc21-1d71-416f-85d2-f20e082ddb4c)
- [FDA Inspection 1061763 - 2018-07-11](https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/5cbbb105-39ae-4fea-b1af-c18f901f4be9)
- [FDA Inspection 963317 - 2016-03-01](https://www.globalkeysolutions.net/records/fda_inspections/lemaitre-vascular-inc/62974030-97ec-455e-9f32-7b3bda73bb46)

Company: https://www.globalkeysolutions.net/companies/lemaitre-vascular-inc/aefe38d0-be3a-4088-a06d-fff4d1e4d063

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d